ArticleJCEM case reports2026
Hypoglycemia secondary to type B insulin resistance syndrome.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Type B insulin resistance syndrome (TBIRS) is rare, with an unknown prevalence, characterized by antibodies directed against the insulin receptor. TBIRS may present with hypoglycemia and/or hyperglycemia. A case of hypoglycemia secondary to TBIRS is reported. A 24-year-old woman presented with hypoglycemia associated with the adrenergic and neuroglycopenic symptoms. Clinical examination was normal. After workup, including a 72-hour fast, glucagon test, autoimmune screen, computerized tomography of the abdomen and calcium stimulation test, no cause was apparent. The results of the 72-hour fast were equivocal. Given the lack of a diagnosis, antibodies to insulin receptors were measured and found to be positive, confirming TBIRS as the cause. Oral glucocorticoid therapy was initiated, and no further hypoglycemic episodes occurred. Steroid therapy resulted in iatrogenic Cushing syndrome. Steroid therapy was discontinued after 1 year of initiation. She delivered a healthy baby with no neonatal hypoglycemia. Hypoglycemic episodes recurred 3 years later, at which point she had relocated and was treated elsewhere. Although rare, autoimmune causes of hypoglycemia should be considered when other causes are excluded or when results are equivocal. Management with pharmacotherapy can be effective in inducing remission but long-term monitoring is necessary as patients may relapse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.